Publikationen in Zusammenarbeit mit Forschern von KU Leuven (5)

2016

  1. Relationship between arterial access and outcomes in ST-elevation myocardial infarction with a pharmacoinvasive versus primary percutaneous coronary intervention strategy: Insights from the STrategic reperfusion early after myocardial infarction (STREAM) study

    Journal of the American Heart Association, Vol. 5, Núm. 6

2009

  1. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial

    JACC: Cardiovascular Interventions, Vol. 2, Núm. 11, pp. 1083-1091

2008

  1. Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the STEEPLE trial

    European Heart Journal, Vol. 29, Núm. 4, pp. 462-471

2006

  1. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

    New England Journal of Medicine, Vol. 355, Núm. 10, pp. 1006-1017

2004

  1. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment. Results of a randomized trial: Beta-Radiation Investigation with Direct stenting and Galileo in Europe (BRIDGE)

    Journal of the American College of Cardiology, Vol. 44, Núm. 3, pp. 528-537